Qing Yang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Cell death & disease

BioMed research international

Cancer management and research

Oxidative medicine and cellular longevity

Shengjing Hospital of China Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shengjing Hospital of China Medical University

China

Director :: Department of Obstetrics & Gynecology

Publications

Jiao Wang, Fei Zheng, Dandan Wang, Qing Yang
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell death & disease 15 (1) (2024)
Jiao Wang, Fei Zheng, Dandan Wang, Qing Yang
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell death & disease 15 (1) (2024)
Jiao Wang, Fei Zheng, Dandan Wang, Qing Yang
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell death & disease 15 (1) (2024)
Jiao Wang, Fei Zheng, Dandan Wang, Qing Yang
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell death & disease 15 (1) (2024)
Jiao Wang, Fei Zheng, Dandan Wang, Qing Yang
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell death & disease 15 (1) (2024)
Jiao Wang, Guipeng Liu, Qing Yang
Parasitic myoma after transabdominal hysterectomy for fibroids: a case report. BMC women's health 23 (1) (2023)
Xiaocui Zhang, Qing Yang
An Immune-Related lncRNA Pairing Model for Predicting the Prognosis and Immune-Infiltrating Cell Condition in Human Ovarian Cancer. BioMed research international 2022 (2022)
Xiaocui Zhang, Meige Sun, Yisheng Jiao, Bei Lin, Qing Yang
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/ β -Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib. Oxidative medicine and cellular longevity 2022 (2022)
Tianshui Sun, Zhuonan Liu, Fangfang Bi, Qing Yang
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Molecular oncology 15 (12) (2021)
Wancheng Zhao, Qing Yang
Lymph-Vascular Space Invasion in Patients with Stages IA2-IIA2 Cervical Cancer Treated with Laparoscopic versus Open Radical Hysterectomy. Cancer management and research 13 (2021)
Yuanyuan An, Qing Yang
Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis. BioMed research international 2020 (2020)
Chunmei Zhang, Yang Li, Wancheng Zhao, Guipeng Liu, Qing Yang
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. Cancer medicine 9 (10) (2020)
Fangfang Bi, Ying Chen, Qing Yang
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer. Cancer cell international 20 (2020)

Qing Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qing Yang